Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis

It was previously believed that obesity and osteoporosis were two unrelated diseases, but recent studies have shown that both diseases share several common genetic and environmental factors. Body fat mass, a component of body weight, is one of the most important indices of obesity, and a substantial body of evidence indicates that fat mass may have beneficial effects on bone. Contrasting studies, however, suggest that excessive fat mass may not protect against osteoporosis or osteoporotic fracture. Differences in experimental design, sample structure, and even the selection of covariates may account for some of these inconsistent or contradictory results. Despite the lack of a clear consensus regarding the impact of effects of fat on bone, a number of mechanistic explanations have been proposed to support the observed epidemiologic and physiologic associations between fat and bone. The common precursor stem cell that leads to the differentiation of both adipocytes and osteoblasts, as well the secretion of adipocyte‐derived hormones that affect bone development, may partially explain these associations. Based on our current state of knowledge, it is unclear whether fat has beneficial effects on bone. We anticipate that this will be an active and fruitful focus of research in the coming years.

[1]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[2]  R. Recker,et al.  Relationship of obesity with osteoporosis. , 2007, The Journal of clinical endocrinology and metabolism.

[3]  S. Allison,et al.  The control of bone remodeling by neuropeptide Y receptors , 2007, Peptides.

[4]  J. Gimble,et al.  Bone and fat , 2004, Endocrine.

[5]  C. Christiansen,et al.  The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis , 1986, Calcified Tissue International.

[6]  I. Reid,et al.  Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. , 2007, American journal of physiology. Endocrinology and metabolism.

[7]  T. Wren,et al.  Fat mass is not beneficial to bone in adolescents and young adults. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  B. Komm,et al.  Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.

[9]  C. Anderson,et al.  Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. , 2006, Endocrinology.

[10]  M. Goran,et al.  Racial Differences in the Association of Subcutaneous and Visceral Fat on Bone Mineral Content in Prepubertal Children , 2006, Calcified Tissue International.

[11]  G. Karsenty,et al.  Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.

[12]  J. Reseland,et al.  Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism , 2006, Journal of cellular biochemistry.

[13]  E. Hennig,et al.  Musculoskeletal disorders associated with obesity: a biomechanical perspective , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[14]  J. Gimble,et al.  Playing with bone and fat , 2006, Journal of cellular biochemistry.

[15]  Guo-xian Ding,et al.  Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity , 2006, Acta Pharmacologica Sinica.

[16]  J. Mao,et al.  Comparison of Osteogenic Potentials of Visceral and Subcutaneous Adipose-Derived Cells of Rabbits , 2006, Plastic and reconstructive surgery.

[17]  M. Eijken,et al.  The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization , 2006, Molecular and Cellular Endocrinology.

[18]  M. Cohen Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling , 2006, American journal of medical genetics. Part A.

[19]  Mary L Bouxsein,et al.  Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.

[20]  T. Niu,et al.  Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. , 2006, The American journal of clinical nutrition.

[21]  M. Malaise,et al.  Interleukin-6: An osteotropic factor influencing bone formation? , 2005, Bone.

[22]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[23]  E. Wagner,et al.  The Molecular Clock Mediates Leptin-Regulated Bone Formation , 2005, Cell.

[24]  M. Lafage-Proust,et al.  Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. , 2005, Endocrinology.

[25]  P. Stewart,et al.  11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action , 2005 .

[26]  Won-Young Lee,et al.  The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle‐aged men , 2005, Clinical endocrinology.

[27]  J. Glowacki,et al.  Hypoxia Inhibition of Adipocytogenesis in Human Bone Marrow Stromal Cells Requires Transforming Growth Factor-β/Smad3 Signaling* , 2005, Journal of Biological Chemistry.

[28]  M. Matsuda,et al.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.

[29]  H. Kroger,et al.  Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.

[30]  J. Jürimäe,et al.  Adiponectin is Associated with Bone Mineral Density in Perimenopausal Women , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  John J. Shin,et al.  Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study , 2005, Nutrition & metabolism.

[32]  A. Uitterlinden,et al.  11β-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation , 2005 .

[33]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[34]  M. St-Onge Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? , 2005, The American journal of clinical nutrition.

[35]  S. Kato,et al.  Nuclear receptors as targets for drug development: crosstalk between peroxisome proliferator-activated receptor gamma and cytokines in bone marrow-derived mesenchymal stem cells. , 2005, Journal of pharmacological sciences.

[36]  J. Seckl 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. , 2004, Current opinion in pharmacology.

[37]  B. Lecka-Czernik,et al.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.

[38]  Matthew R. Smith Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. , 2004, The Journal of urology.

[39]  S. Farmer,et al.  Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis , 2004, Journal of Biological Chemistry.

[40]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[41]  Jeremy W Tomlinson,et al.  11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response , 2004 .

[42]  A. Rissanen,et al.  Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  H. Herzog,et al.  NPY and Y receptors: lessons from transgenic and knockout models , 2004, Neuropeptides.

[44]  T. Thomas The complex effects of leptin on bone metabolism through multiple pathways. , 2004, Current opinion in pharmacology.

[45]  C. Gutiérrez,et al.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. , 2004, Obesity research.

[46]  M. Zemel,et al.  Role of calcium and dairy products in energy partitioning and weight management. , 2004, The American journal of clinical nutrition.

[47]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[48]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[49]  U. Dafni,et al.  Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[51]  P. Tontonoz,et al.  Fat's loss is bone's gain. , 2004, The Journal of clinical investigation.

[52]  D. Xie,et al.  Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. , 2004, Bone.

[53]  I. Reid Leptin deficiency--lessons in regional differences in the regulation of bone mass. , 2004, Bone.

[54]  C. Laplace,et al.  Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo , 2004, The Journal of cell biology.

[55]  T. Martin,et al.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. , 2004, The Journal of clinical investigation.

[56]  J. Glowacki,et al.  Cooperation Between TGF‐β and Wnt Pathways During Chondrocyte and Adipocyte Differentiation of Human Marrow Stromal Cells , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[58]  Arya M. Sharma,et al.  Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss , 2004 .

[59]  S. Farmer,et al.  Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. , 2004, The Journal of biological chemistry.

[60]  Laura Maffei,et al.  Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[61]  B. Walker,et al.  Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. , 2004, Recent progress in hormone research.

[62]  L. Mosekilde,et al.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis , 2004, Biogerontology.

[63]  Stanley B. Cohen,et al.  Oral glucocorticoid use is associated with an increased risk of fracture , 2004, Osteoporosis International.

[64]  H. Herzog Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. , 2003, European journal of pharmacology.

[65]  K. Lohman,et al.  Adiponectin as a novel determinant of bone mineral density and visceral fat. , 2003, Bone.

[66]  C. Schwarzer,et al.  Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice , 2003, Molecular and Cellular Biology.

[67]  R. Eastell,et al.  11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone , 2003 .

[68]  L. Melton,et al.  Adverse Outcomes of Osteoporotic Fractures in the General Population , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[70]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[71]  R. Recker,et al.  Molecular and genetic mechanisms of obesity: implications for future management. , 2003, Current molecular medicine.

[72]  W. Rand,et al.  Leptin, Body Composition and Bone Mineral Density in Premenopausal Women , 2003, Calcified Tissue International.

[73]  C. Mantzoros,et al.  Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[74]  T. Thomas Leptin: a potential mediator for protective effects of fat mass on bone tissue. , 2003, Joint, bone, spine : revue du rhumatisme.

[75]  P. Vestergaard,et al.  Hormone Replacement Therapy Dissociates Fat Mass and Bone Mass, and Tends to Reduce Weight Gain in Early Postmenopausal Women: A Randomized Controlled 5‐Year Clinical Trial of the Danish Osteoporosis Prevention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  J. Després,et al.  The interleukin 6 –174G/C Polymorphism is associated with indices of obesity in men , 2003, Journal of Human Genetics.

[77]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[78]  I. Reid Relationships among body mass, its components, and bone. , 2002, Bone.

[79]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[80]  P. Hees,et al.  Fitness, fatness and activity as predictors of bone mineral density in older persons , 2002, Journal of internal medicine.

[81]  D. Giannella‐Neto,et al.  Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[82]  I. Reid,et al.  Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. , 2002, The Journal of endocrinology.

[83]  A. Geliebter,et al.  Amylin, food intake, and obesity. , 2002, Obesity research.

[84]  J. Cornish,et al.  Amylin and adrenomedullin: novel regulators of bone growth. , 2002, Current pharmaceutical design.

[85]  B. Burguera,et al.  Is Leptin the Link Between Fat and Bone Mass? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[86]  David E. Misek,et al.  Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.

[87]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[88]  T. Hökfelt,et al.  Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Kirkland,et al.  Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.

[90]  M. Cooper,et al.  Osteoblastic 11β‐Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[91]  Toshio Matsumoto,et al.  Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines That Express Estrogen Receptor (er) ␣ or ␤ , 2022 .

[92]  J. Lehmann,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Divergent Effects of Selective Peroxisome Proliferator- Activated Receptor-�2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2022 .

[93]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[94]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[95]  G. Thomas,et al.  Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.

[96]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[97]  J. Lehmann,et al.  Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor- (cid:1) 2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2002 .

[98]  Toshio Matsumoto,et al.  Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. , 2002, Endocrinology.

[99]  L. Rossetti,et al.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.

[100]  C. Buchanan,et al.  Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. , 2001, The Biochemical journal.

[101]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[102]  M. Mędraś,et al.  Are general obesity and visceral adiposity in men linked to reduced bone mineral content resulting from normal ageing? A population‐based study , 2001, Andrologia.

[103]  M. Visser,et al.  Determinants of Bone Mineral Density in Older Men and Women: Body Composition as Mediator , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[104]  U. Das Is obesity an inflammatory condition? , 2001, Nutrition.

[105]  Sheila M. Williams,et al.  Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. , 2001, The Journal of pediatrics.

[106]  B. Ottesen,et al.  Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. , 2001, Obesity research.

[107]  L. Melton,et al.  The Prevalence of Osteoporosis: Gender and Racial Comparison , 2001, Calcified Tissue International.

[108]  B. Wisse,et al.  Role of melanocortins in control of obesity , 2001, The Lancet.

[109]  K. Chihara,et al.  Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women , 2001, Clinical endocrinology.

[110]  A. Genazzani,et al.  Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. , 2001, Maturitas.

[111]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[112]  J. Manson,et al.  Clinical practice. Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.

[113]  P. Heine,et al.  The role of estrogen and estrogen receptor-α in male adipose tissue , 2001, Molecular and Cellular Endocrinology.

[114]  J. Hopper,et al.  Changes in Body Composition as Determinants of Longitudinal Changes in Bone Mineral Measures in 8 to 26-year-old Female Twins , 2001, Osteoporosis International.

[115]  Jeannie S. Huang,et al.  Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy , 2001, AIDS.

[116]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[117]  J. Pasco,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Serum Leptin Levels Are Associated with Bone Mass in , 2022 .

[118]  T. Olsson,et al.  Tissue-specific dysregulation of cortisol metabolism in human obesity. , 2001, The Journal of clinical endocrinology and metabolism.

[119]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[120]  P. Heine,et al.  The role of estrogen and estrogen receptor-alpha in male adipose tissue. , 2001, Molecular and cellular endocrinology.

[121]  H. Hsiung,et al.  Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. , 2001, Endocrinology.

[122]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[123]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[124]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .

[125]  Yoichi Kato,et al.  LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.

[126]  M. Cooper,et al.  Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. , 2000, Bone.

[127]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[128]  D. Pennica,et al.  Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. , 2000, Cytokine.

[129]  T. Douchi,et al.  Relationship Between Body Fat Distribution and Bone Mineral Density in Premenopausal Japanese Women , 2000, Obstetrics and gynecology.

[130]  P. Kopelman Obesity as a medical problem , 2000, Nature.

[131]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[132]  B. Walker,et al.  Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. , 2000, Endocrinology.

[133]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[134]  J. Woo,et al.  Vertebral Deformity in Chinese Men: Prevalence, Risk Factors, Bone Mineral Density, and Body Composition Measurements , 2000, Calcified Tissue International.

[135]  C. Christiansen,et al.  Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[136]  T. Rönnemaa,et al.  Bone mineral density in patients with type 1 and type 2 diabetes. , 1999, Diabetes care.

[137]  K. Hotta,et al.  Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[138]  C. Mantzoros The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence , 1999, Annals of Internal Medicine.

[139]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[140]  R. Oreffo,et al.  Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts , 1999, Cell biology international.

[141]  JC Seidell,et al.  Obesity: a growing problem , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[142]  L. Khaodhiar,et al.  Obesity and its comorbid conditions. , 1999, Clinical cornerstone.

[143]  C. Marcelli,et al.  Evolution of Lumbar Bone Mineral Content During Adolescence and Adulthood: A Longitudinal Study in 395 Healthy Females 10–24 Years of Age and 206 Premenopausal Women , 1999, Osteoporosis International.

[144]  A. Goulding,et al.  Plasma Leptin Values in Relation to Bone Mass and Density and to Dynamic Biochemical Markers of Bone Resorption and Formation in Postmenopausal Women , 1998, Calcified Tissue International.

[145]  S. C. Lin,et al.  Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. , 1998, Proceedings of the Association of American Physicians.

[146]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[147]  B. L. Riggs,et al.  A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[148]  T. Hangartner,et al.  Relation of nutrition, body composition and physical activity to skeletal development: a cross-sectional study in preadolescent females. , 1998, Journal of the American College of Nutrition.

[149]  G A Colditz,et al.  Current estimates of the economic cost of obesity in the United States. , 1998, Obesity research.

[150]  H. Sul,et al.  Understanding adipocyte differentiation. , 1998, Physiological reviews.

[151]  J. Callés-Escandon,et al.  Menopause, central body fatness, and insulin resistance: effects of hormone‐replacement therapy , 1998, Coronary artery disease.

[152]  Edwards,et al.  11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .

[153]  T. Douchi,et al.  The effect of body composition on bone density in pre- and postmenopausal women. , 1997, Maturitas.

[154]  P. Stewart,et al.  Does central obesity reflect “Cushing's disease of the omentum”? , 1997, The Lancet.

[155]  M. Aickin,et al.  Fat or Lean Tissue Mass: Which One Is the Major Determinant of Bone Mineral Mass in Healthy Postmenopausal Women? , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[156]  L. Melton,et al.  Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[157]  B. Tarquini,et al.  Evidence for bone mass and body fat distribution relationship in postmenopausal obese women. , 1997, Archives of gerontology and geriatrics.

[158]  E. Barrett-Connor,et al.  Does Hyperinsulinemia Preserve Bone? , 1996, Diabetes Care.

[159]  I. Reid Therapy of osteoporosis: calcium, vitamin D, and exercise. , 1996, The American journal of the medical sciences.

[160]  J. Lehmann,et al.  Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.

[161]  L. Melton,et al.  Relationship between body composition and bone mass in women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[162]  A. Hofman,et al.  Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. , 1996, Bone.

[163]  Su‐Li Cheng,et al.  Expression of bone matrix proteins during dexamethasone‐induced mineralization of human bone marrow stromal cells , 1996, Journal of cellular biochemistry.

[164]  I. Sartori Increasing Prevalence of Overweight Among US Adults , 1996 .

[165]  E. Simpson,et al.  Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.

[166]  C Milgrom,et al.  Aging and matrix microdamage accumulation in human compact bone. , 1995, Bone.

[167]  I. Reid,et al.  Regular exercise dissociates fat mass and bone density in premenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[168]  C. Heiss,et al.  Associations of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[169]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[170]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[171]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[172]  I. Reid,et al.  Determinants of the rate of bone loss in normal postmenopausal women. , 1994, The Journal of clinical endocrinology and metabolism.

[173]  R. Marcus,et al.  Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[174]  K. Flegal,et al.  Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .

[175]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[176]  R. Dodds,et al.  Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[177]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[178]  L. Bonewald,et al.  Role of active and latent transforming growth factor beta in bone formation. , 1994, Journal of cellular biochemistry.

[179]  J. Wozney,et al.  Transforming growth factor-beta gene family members and bone. , 1994, Endocrine reviews.

[180]  K. Martin,et al.  Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.

[181]  C C Glüer,et al.  Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[182]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[183]  J J Anderson,et al.  Effects of weight and body mass index on bone mineral density in men and women: The framingham study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[184]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[185]  I. Reid,et al.  Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. , 1992, The Journal of clinical endocrinology and metabolism.

[186]  I. Reid,et al.  Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. , 1992, The Journal of clinical endocrinology and metabolism.

[187]  G. Rodan Introduction to bone biology. , 1992, Bone.

[188]  M. Wabitsch,et al.  Control of terminal differentiation of adipose precursor cells by glucocorticoids. , 1991, Journal of lipid research.

[189]  R. Mazess,et al.  Spine and femur density using dual-photon absorptiometry in US white women. , 1987, Bone and mineral.

[190]  H. Spencer,et al.  Factors Contributing to Osteoporosis , 1986 .

[191]  H. Spencer,et al.  NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis. , 1986, The Journal of nutrition.

[192]  T. Bartness,et al.  Gonadal influences on adiposity. , 1985, International journal of obesity.